Humana Inc.: Managing In A Changing Industry Harvard Case Solution & Analysis

Humana Inc.: Managing In A Changing Industry Case Study Solution

Spin-off DCF Valuation

A DCF valuation for one of the most important strategic restructuring option could be conducted to evaluate the change in the value of the firm after the spin-off. The DCF valuation of Spin-off could be conducted on a perpetuity basis with assuming inflation rate as the growth rate. In this regards, a hurdle rate is calculated for each of the business segment separately and for Humana as whole using the given data for 1991. The assumptions for calculating the hurdle rate are as follows;

  • Unlevered Beta is taken as an industry average from hospitals organizations as most of the revenues of the organizations depends upon its hospital segment.
  • Market risk premium is assumed to be 5% on general assumption basis.
  • Cost of debt is calculated by using 1991 interest expense and LTD
  • Tax Rate is calculated by using 1991 taxes paid and the 1991 EBIT.

On the basis of given data, the WACC for Humana Inc. equals to 8.74% and the WACC for Hospitals and Health Plan business segment equals to 8.99% and 8.99% respectively. The DCF valuation before spin-off for Humana shows an enterprise value of $551 million, given in the Exhibit 1. However, the DCF valuation for Humana with considering both of the business segments separately shows an enterprise value of $2500 million. The spin-off could provide an increase in the value of the company by 354% and a share price of $12 per share. (Brigham, 2016)

Conclusion

Although, the share prices of the firm are declining in the market due to the overall low profitability of the company. But the overall value of the firm could be increased by considering the corporate spin-off strategy and separating the highly profitable Hospital business segment from low profitable Health Plan business segment. It could lead to an increase in the value of the firm which could ultimately increase the value per share and the total shareholders’ wealth.

 

Exhibits

Exhibit-1: DCF Valuation of Spin-off

Valuation Before Spin off
  Humana
EBITDA 845
Depreciation and Amortization 256
EBIT 589
Tax Rate 36%
NOPAT 377
Add: Depreciation and Amortization 256
Less: Capital Expenditures 586
Free Cash Flow 47
WACC 8.74%
Growth Rate (Inflation Rate) 3%
Present Value (Perpetuity Basis)  $551

 

Valuation After Spin off
  Hospitals Health Plans Humana
EBITDA 904 100 845
Depreciation and Amortization 210 26 256
EBIT 694 74 589
Tax Rate 36% 36% 36%
NOPAT 444 47 377
Add: Depreciation and Amortization 210 26 256
Less: Capital Expenditures 396 113 586
Free Cash Flow 258 -40 47
WACC 8.99% 8.99% 8.74%
Growth Rate (Inflation Rate) 3% 3% 3%
Present Value (Perpetuity Basis) 2955 -455 551
Total Value of Each Segment  $           2,500

Exhibit-2: Balance Sheet after Spin-off

Balance Sheet
 (in millions except per share data)
  Hospitals Health Plans
Assets:    
Assets 2239 445
Total Assets 2239 445
Liabilities and Equity:
Liabilities 704 142
Equity 1535 303
Total Liabilities and Equity 2239 445
No. of Shares Outstanding 132 26
Value Per Share 12 12

 

This is just a sample partical work. Please place the order on the website to get your own originally done case solution.

How We Work?
Just email us your case materials and instructions to order@thecasesolutions.com and confirm your order by making the payment here

Share This

SALE SALE

Save Up To

30%

IN ONLINE CASE STUDY

FOR FREE CASES AND PROJECTS INCLUDING EXCITING DEALS PLEASE REGISTER YOURSELF !!

Register now and save up to 30%.